Recreational use of phenytoin, marijuana, and alcohol: A case report
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The neurologic sequela of recreational abuse of prescription medication and illicit drugs is a significant cause of presentation to emergency departments. Phenytoin is not widely known for its potential as a recreational street drug. I report a case of phenytoin sold as a street drug, which led to phenytoin toxicity after being taken with marijuana.
Case report.
A man aged 19 years smoked marijuana, drank beer, and “sipped syrup” to get “high.” The patient’s mother brought the patient to the emergency department because he could not walk, fell multiple times to the left resulting in mild head trauma, and had slurred speech and vomiting for the past 2 days. On examination, he was …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Research
Association between recent cannabinoid use and acute ischemic strokeCarmela V. San Luis, Christa O'Hana S. Nobleza, Shashank Shekhar et al.Neurology: Clinical Practice, June 03, 2020 -
Eye on Practice
Clinical perspectives on medical marijuana (cannabis) for neurologic disordersTerry D. Fife, Heidi Moawad, Constantine Moschonas et al.Neurology: Clinical Practice, August 06, 2015 -
Articles
Effects of cannabis on cognitive function in patients with multiple sclerosisKimia Honarmand, Mary C. Tierney, Paul O'Connor et al.Neurology, March 28, 2011 -
Article
Disparities and guideline adherence in drugs of abuse screening in intracerebral hemorrhageLaura M. Tormoehlen, Ashley D. Blatsioris, Elizabeth A.S. Moser et al.Neurology, December 07, 2016